Wolf‐Karsten Hofmann
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 88
- Chronic Myeloid Leukemia Treatments 59
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 33
- Myeloproliferative Neoplasms: Diagnosis and Treatment 24
- Immunology top 2%
- Mast cells and histamine 27
- Cancer Research top 2%
- Rheumatology top 1%
- Eosinophilic Disorders and Syndromes 37
-
- Acute Lymphoblastic Leukemia research 37
-
- Epigenetics and DNA Methylation 18
- Co-authors
- Stefanie DimmelerDieter HoelzerAndreas M. ZeiherEckhard ThielOliver G. OttmannAlice FabariusThomas J. VoglBirgit Aßmus
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Wolf‐Karsten Hofmann
238 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Hematology 2.6k
- Genetics 1.9k
- Immunology 1.1k
- Cancer Research 805
- Rheumatology 682
Countries citing papers authored by Wolf‐Karsten Hofmann
This map shows the geographic impact of Wolf‐Karsten Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolf‐Karsten Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolf‐Karsten Hofmann more than expected).
Fields of papers citing papers by Wolf‐Karsten Hofmann
This network shows the impact of papers produced by Wolf‐Karsten Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolf‐Karsten Hofmann. The network helps show where Wolf‐Karsten Hofmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wolf‐Karsten Hofmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 0 | |
| 5 | 2021 | 89 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 4 | |
| 9 | 2017 | 13 | |
| 10 | 2015 | 14 | |
| 11 | 2013 | 143 | |
| 12 | 2013 | 80 | |
| 13 | 2012 | 2 | |
| 14 | 2012 | 28 | |
| 15 | 2010 | 31 | |
| 16 | 2006 | 11 | |
| 17 | 2005 | 34 | |
| 18 | 2004 | 7 | |
| 19 | Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarctionbreakdown → | 2004 | 813 |
| 20 | 2000 | 122 |
About Wolf‐Karsten Hofmann
Wolf‐Karsten Hofmann is a scholar working on Hematology, Genetics, Rheumatology, Immunology and Public Health, Environmental and Occupational Health, having authored 251 papers that have together received 6.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (88 papers), Chronic Myeloid Leukemia Treatments (59 papers), Eosinophilic Disorders and Syndromes (37 papers), Acute Lymphoblastic Leukemia research (37 papers), Chronic Lymphocytic Leukemia Research (33 papers), Mast cells and histamine (27 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (24 papers) and Epigenetics and DNA Methylation (18 papers). The work is most often cited by research in Hematology (2.6k citations), Genetics (1.9k citations), Immunology (1.1k citations), Cancer Research (805 citations) and Rheumatology (682 citations). Wolf‐Karsten Hofmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Stefanie Dimmeler, Dieter Hoelzer, Andreas M. Zeiher, Eckhard Thiel, Oliver G. Ottmann, Alice Fabarius, Thomas J. Vogl, Birgit Aßmus, Nasreddin Abolmaali and Volker Schächinger. Their work appears in journals such as Blood, Annals of Hematology, Leukemia Research, PLoS ONE and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.